Search research articles
Contact Us
Filters
Showing results (1331-1340 of 1,553) with videos related to
Page
of 156
Sort By:
Radiology
|
February 1, 2022
Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial
Kanglian Zheng, Xu Zhu, Shijie Fu, et al.
Gastrointestinal Endoscopy
|
September 20, 2020
Size of Lugol-unstained lesions as a predictor for risk of progression in premalignant lesions of the esophagus
Mengfei Liu, Ren Zhou, Chuanhai Guo, et al.
Brain : a Journal of Neurology
|
January 1, 2019
MMP13 inhibition rescues cognitive decline in Alzheimer transgenic mice via BACE1 regulation
Bing-Lin Zhu, Yan Long, Wei Luo, et al.
BMC Cancer
|
August 13, 2024
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
Joon Oh Park, Yin-Hsun Feng, Wu-Chou Su, et al.
The Lancet. Gastroenterology & Hepatology
|
October 9, 2021
Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial
Rui-Hua Xu, Yanqiao Zhang, Hongming Pan, et al.
World Journal of Gastroenterology
|
August 6, 2008
Celecoxib-related gastroduodenal ulcer and cardiovascular events in a randomized trial for gastric cancer prevention
Guo-Shuang Feng, Jun-Ling Ma, Benjamin C Y Wong, et al.
The Lancet. Oncology
|
November 2, 2013
Management of gastric cancer in Asia: resource-stratified guidelines
Lin Shen, Yan-Shen Shan, Huang-Ming Hu, et al.
Nanoscale
|
December 16, 2015
Bridging the "green gap" of LEDs: giant light output enhancement and directional control of LEDs via embedded nano-void photonic crystals
Yu-Lin Tsai, Che-Yu Liu, Chirenjeevi Krishnan, et al.
The Lancet. Oncology
|
April 18, 2015
Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial
Jean-Yves Blay, Lin Shen, Yoon-Koo Kang, et al.
Frontiers in Immunology
|
September 26, 2022
Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced gastrointestinal cancers
Yanni Wang, Jianling Zou, Yun Li, et al.
Page
of 156
Search research articles
Search
Showing results (1331-1340 of 1,553) with videos related to
Sort By:
Page
of 156
Radiology
|
February 1, 2022
Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial
Kanglian Zheng, Xu Zhu, Shijie Fu, et al.
Gastrointestinal Endoscopy
|
September 20, 2020
Size of Lugol-unstained lesions as a predictor for risk of progression in premalignant lesions of the esophagus
Mengfei Liu, Ren Zhou, Chuanhai Guo, et al.
Brain : a Journal of Neurology
|
January 1, 2019
MMP13 inhibition rescues cognitive decline in Alzheimer transgenic mice via BACE1 regulation
Bing-Lin Zhu, Yan Long, Wei Luo, et al.
BMC Cancer
|
August 13, 2024
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
Joon Oh Park, Yin-Hsun Feng, Wu-Chou Su, et al.
The Lancet. Gastroenterology & Hepatology
|
October 9, 2021
Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial
Rui-Hua Xu, Yanqiao Zhang, Hongming Pan, et al.
World Journal of Gastroenterology
|
August 6, 2008
Celecoxib-related gastroduodenal ulcer and cardiovascular events in a randomized trial for gastric cancer prevention
Guo-Shuang Feng, Jun-Ling Ma, Benjamin C Y Wong, et al.
The Lancet. Oncology
|
November 2, 2013
Management of gastric cancer in Asia: resource-stratified guidelines
Lin Shen, Yan-Shen Shan, Huang-Ming Hu, et al.
Nanoscale
|
December 16, 2015
Bridging the "green gap" of LEDs: giant light output enhancement and directional control of LEDs via embedded nano-void photonic crystals
Yu-Lin Tsai, Che-Yu Liu, Chirenjeevi Krishnan, et al.
The Lancet. Oncology
|
April 18, 2015
Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial
Jean-Yves Blay, Lin Shen, Yoon-Koo Kang, et al.
Frontiers in Immunology
|
September 26, 2022
Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced gastrointestinal cancers
Yanni Wang, Jianling Zou, Yun Li, et al.
Page
of 156